Skip to main navigation Skip to search Skip to main content

Cetoacidosis diabética y estado hiperglucémico hiperosmolar en COVID-19. Reporte de casos

  • Goethe Salomon Sacoto Flores (First Author)
  • , Galo Dario Sanchez Coraizaca
  • , Luis Andres Cajilema Acero
  • , Maria Ximena Sanango Jara (Last Author)

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Introduction: Diabetes Mellitus (DM) is an independent risk factor to predict severity in COVID-19 infection.Clinical cases: we present four cases of hyperglycemic seizures type hyperosmolar nonketotic state (EHNC) and diabetic ketoacidosis (DKA) associated with COVID-19, three with a history of DM and one with a new diagnosis of DM. The outcome was fatal for the CAD cases and the EHNC case was discharged in stable condition.Conclusion: it is essential to understand the presentation characteristics of acute complications of diabetes in patients with COVID-19 and to suspect this type of metabolic alterations in SARS-CoV-2 infection, important aspects for a timely diagnosis and treatment, greatly improving the prognosis of patients
Original languageSpanish
JournalRevista de la Facultad de Ciencias Médicas de la Universidad de Cuenca
StatePublished - 1 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19; Diabetes mellitus; Cetoacidosis diabética

Cite this